OSE Immunotherapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.55	16.75	18.67	25.62	33.58
Short-Term Investments	5.1	42.37	-	-	-
Cash & Short-Term Investments	22.65	59.12	18.67	25.62	33.58
Cash Growth	-61.69%	216.61%	-27.12%	-23.70%	14.34%
Accounts Receivable	0.44	4.17	1.15	0.4	0.77
Other Receivables	5.93	3.14	6.44	5.98	5.18
Receivables	6.37	7.31	7.59	6.39	5.95
Prepaid Expenses	0.72	2.29	2.75	3.45	2.96
Other Current Assets	2.24	1.22	1.47	1.74	1.72
Total Current Assets	31.99	69.93	30.48	37.2	44.21
Property, Plant & Equipment	3.68	3.43	4.07	4.98	5.44
Long-Term Investments	-	5.05	-	-	-
Other Intangible Assets	0	0.11	0.14	0.17	0.15
Long-Term Deferred Tax Assets	0.19	0.19	0.2	0.18	0.17
Long-Term Deferred Charges	41.54	43.9	46.26	48.62	50.97
Other Long-Term Assets	1.46	1.36	0.91	0.64	0.94
Total Assets	78.86	123.96	82.05	91.78	101.88
Accounts Payable	8.82	7.72	9.3	8.54	9.61
Accrued Expenses	2.81	2.4	-	2.92	3.72
Current Portion of Long-Term Debt	10.89	7.2	6.4	3.09	1.61
Current Portion of Leases	0.77	0.6	0.86	0.88	0.76
Current Income Taxes Payable	0.41	0.26	1.89	0.02	0.01
Current Unearned Revenue	1.19	2.03	0.35	0.81	1.05
Other Current Liabilities	0.01	0	0.01	0	0
Total Current Liabilities	24.9	20.22	18.8	16.27	16.76
Long-Term Debt	21.83	35.66	35.51	37.23	30.8
Long-Term Leases	2.81	2.68	3.03	3.59	3.97
Long-Term Unearned Revenue	-	0.1	-	-	-
Pension & Post-Retirement Benefits	0.35	0.42	0.43	0.43	0.42
Long-Term Deferred Tax Liabilities	1.22	1.07	1.31	1.51	1.75
Other Long-Term Liabilities	-	-	-	0.09	0.29
Total Liabilities	51.1	60.15	59.08	59.12	53.99
Common Stock	4.49	4.39	4.33	3.71	3.71
Additional Paid-In Capital	77.71	77.74	76.64	65.61	65.61
Retained Earnings	-37.69	37.45	-23	-17.76	-16.85
Treasury Stock	-0.34	-0.45	-0.41	-0.55	-0.16
Comprehensive Income & Other	-16.42	-55.32	-34.59	-18.35	-4.41
Shareholders' Equity	27.76	63.81	22.98	32.66	47.89
Total Liabilities & Equity	78.86	123.96	82.05	91.78	101.88
Total Debt	36.29	46.13	45.8	44.79	37.13
Net Cash (Debt)	-13.65	12.99	-27.13	-19.17	-3.55
Net Cash Per Share	-0.61	0.51	-1.39	-1.03	-0.20
Filing Date Shares Outstanding	23.52	22.31	21.59	18.45	18.49
Total Common Shares Outstanding	22.42	21.9	21.59	18.46	18.49
Working Capital	7.09	49.71	11.68	20.93	27.45
Book Value Per Share	1.24	2.91	1.06	1.77	2.59
Tangible Book Value	27.76	63.7	22.84	32.49	47.74
Tangible Book Value Per Share	1.24	2.91	1.06	1.76	2.58
Buildings	0.32	0.32	0.32	0.31	0.36
Machinery	1.83	1.74	1.67	1.71	1.55